Bordetella pertussisfimbriae (Fim): relevance for vaccines

Pertussis Vaccine Trials in the 1990s

(2014) L. C. Lambert   JOURNAL OF INFECTIOUS DISEASES

Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

(2013) Hans Hallander et al.   Clinical and Vaccine Immunology

Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark

(2013) P. F. RØNN et al.   EPIDEMIOLOGY AND INFECTION

Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan

(2013) Yusuke Miyaji et al.   PLoS One

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Seroprevalence of pertussis in China

(2013) Ying Hua Xu et al.   Human Vaccines & Immunotherapeutics

The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study

(2012) Qi Zhang et al.   BMC INFECTIOUS DISEASES

Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease

(2012) Frances Alexander et al.   Clinical and Vaccine Immunology

Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

(2012) J M Warfel et al.   Mucosal Immunology

Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps

(2012) Marjolein van Gent et al.   PLoS One

Complete Genome Sequence of Bordetella pertussis CS, a Chinese Pertussis Vaccine Strain

(2011) S. Zhang et al.   JOURNAL OF BACTERIOLOGY

Different Requirements for σ Region 4 in BvgA Activation of the Bordetella pertussis Promoters Pfim3 and PfhaB

(2011) Kimberly B. Decker et al.   JOURNAL OF MOLECULAR BIOLOGY

A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins

(2011) Burcu E. Tefon et al.   VACCINE

Improving sequencing quality from PCR products containing long mononucleotide repeats

(2010) Aron Fazekas et al.   BIOTECHNIQUES

Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis

(2010) J. D. Cherry et al.   Clinical and Vaccine Immunology

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology

Interactions between Bordetella pertussis and the complement inhibitor factor H

(2010) Hanne Amdahl et al.   MOLECULAR IMMUNOLOGY

Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA

(2010) Qing Chen et al.   MOLECULAR MICROBIOLOGY

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

(2010) Sabine C. de Greeff et al.   PLoS One

Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis

(2009) Yinghua Xu et al.   BMC MICROBIOLOGY

Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience

(2009) Hans O Hallander et al.   Expert Review of Vaccines

Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen

(2009) Frits R. Mooi   INFECTION GENETICS AND EVOLUTION

Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type

(2009) D. J. Litt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bordetella pertussis Isolates in Finland: Serotype and Fimbrial Expression

(2008) Eriikka Heikkinen et al.   BMC MICROBIOLOGY